Unique ID issued by UMIN | UMIN000023861 |
---|---|
Receipt number | R000027490 |
Scientific Title | The clinical evaluation about the bowel movement improvement effected by the dietary fiber-containing jelly drink intake. |
Date of disclosure of the study information | 2016/09/01 |
Last modified on | 2018/05/24 22:16:52 |
The clinical evaluation about the bowel movement improvement effected by the dietary fiber-containing jelly drink intake.
The clinical evaluation of the bowel movement improvement effected by the dietary fiber-containing jelly drink intake.
The clinical evaluation about the bowel movement improvement effected by the dietary fiber-containing jelly drink intake.
The clinical evaluation of the bowel movement improvement effected by the dietary fiber-containing jelly drink intake.
Japan |
Constipation
Gastroenterology |
Others
NO
To assess bowel movement improvement effect of dietary fiber-containing jelly
Efficacy
Confirmatory
Pragmatic
Not applicable
Number of defecation per day (Defecation rate)
Defecation frequency, fecal property, amount of feces, number of days and frequency of laxative use
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Food |
One pouch of dietary fiber-containing jelly is to be taken each day on 14 consecutive days after 14 days of non-intake period.
A total of 100 mL water is to be taken each day on 14 consecutive days after 14 days of non-intake period.
65 | years-old | <= |
Not applicable |
Male and Female
1) Patient considered to have functional constipation
2) Patient aware of what and how much he/she takes
3) Patient who has consumed at least 80% of the meal offered before the start of the study
4) Patient who is in a hospital or in a healthcare facility
1) Patient considered to have organic constipation
2) Patient who has metabolic disorder
3) Patient treated with opium alkaloid, anticholinergic drug, anesthetic drug, hypotensive drug having ganglionic blocking action, or antidepressant drug
4) Patient who has neuropathy
5) Patient who has markedly painful hemorrhoid, anal fissure, or anal fistula, etc.
6) Patient who has artificial anus
7) Patient who developed aspiration pneumonia within one month
8) Patient who takes dietary fiber contained in fluid diet or other food products by 15 g/day or more in total
9) Patient who was determined to be ineligible for the assessment by a doctor
100
1st name | |
Middle name | |
Last name | Sadao Yoshida |
Okinawa Medical Hospital
internal medicine
Nishihara2310, Sashiki Tsuhako, Nanjyo-shi, Okinawa, 901-1414, Japan
098-947-3555
info@rinsyou-siken.jp
1st name | |
Middle name | |
Last name | Sadao Yoshida |
Okinawa Medical Hospital
internal medicine
Nishihara2310, Sashiki Tsuhako, Nanjyo-shi, Okinawa, 901-1414, Japan
098-947-3555
info@rinsyou-siken.jp
Okinawa Medical Hospital
NUTRI Co., Ltd.
Profit organization
Japan
NO
2016 | Year | 09 | Month | 01 | Day |
Unpublished
No longer recruiting
2016 | Year | 08 | Month | 22 | Day |
2016 | Year | 09 | Month | 01 | Day |
2017 | Year | 06 | Month | 30 | Day |
2016 | Year | 08 | Month | 31 | Day |
2018 | Year | 05 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027490
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |